Slideshow

Osteoarthritis: 3 Things to Know

Author(s):

(1) Questionable efficacy of knee injections, (2) a dramatic increase in the prevalence of osteoarthritis, and (3) a promising molecular biomarker.

References1. Bedard NA, DeMik DE, Glass NA, et al. Impact of clinical practice guidelines on use of intra-articular hyaluronic acid and corticosteroid injections for knee osteoarthritis. J Bone Joint Surg Am. 2018;100:827-834. doi: 10.2106/JBJS.17.01045.2. Park J, Mendy A, Vieira ER. Various types of arthritis in the United States: prevalence and age-related trends from 1999 to 2014. Am J Public Health. 2018;108:256-258. doi: 10.2105/AJPH.2017.304179.3. Rivas F, Zahid OK, Reesink HL, et al. Label-free analysis of physiological hyaluronan size distribution with a solid-state nanopore sensor. Nature Communications. 2018;9:1037. Published March 12, 2018.

Related Videos
The Evolving Use of Biologics for PsA Care, with Philip Mease, MD
Achieving Complete Renal Response and Reducing Corticosteroid Use in Lupus Nephritis Treatment With Obinutuzmab, with Richard Furie, MD
Identifying B-cell Depleting Agents for Lupus Nephritis, with Richard Furie, MD
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
© 2025 MJH Life Sciences

All rights reserved.